These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Effects of suloctidil on the central and peripheral nervous systems]. Nishi H; Watanabe T; Mori M Nihon Yakurigaku Zasshi; 1983 Sep; 82(3):191-212. PubMed ID: 6319248 [TBL] [Abstract][Full Text] [Related]
7. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system. Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacological studies on 2-methyl-4-amino-6-methoxy-s-triazine (CV399); with special reference to its central effects]. Chiba S; Nagawa Y; Yui T Nihon Yakurigaku Zasshi; 1970; 66(1):64-75. PubMed ID: 4393359 [No Abstract] [Full Text] [Related]
9. Effects of azelastine hydrochloride, a novel anti-allergic drug, on the central nervous system. Kaneko T; Kitahara A; Ozaki S; Takizawa K; Yamatsu K Arzneimittelforschung; 1981; 31(8):1206-12. PubMed ID: 6117290 [TBL] [Abstract][Full Text] [Related]
10. General pharmacological properties of cilostazol, a new antithrombotic drug. Part I: Effects on the central nervous system. Shintani S; Toba Y; Suzuki S; Ninomiya S; Umezato M; Hiyama T Arzneimittelforschung; 1985; 35(7A):1157-62. PubMed ID: 4074429 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system. Sieroslawska J; Hano J; Sypniewska M; Czarnecki R; Chojnacka-Wójcik E; Harasiewicz A Pol J Pharmacol Pharm; 1973; 25(1):1-16. PubMed ID: 4798097 [No Abstract] [Full Text] [Related]
12. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties. Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological studies on timiperone, a new neuroleptic drug. Part I: Behavior effects. Yamasaki T; Kojima H; Sakurai T; Kasahara A; Watanabe S; Fujiwara M; Ueki S Arzneimittelforschung; 1981; 31(4):701-7. PubMed ID: 6113833 [No Abstract] [Full Text] [Related]
14. Effect of skimmianine on animal behavior. Cheng JT Arch Int Pharmacodyn Ther; 1986 May; 281(1):35-43. PubMed ID: 3753096 [TBL] [Abstract][Full Text] [Related]
16. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests. Bristow LJ; Collinson N; Cook GP; Curtis N; Freedman SB; Kulagowski JJ; Leeson PD; Patel S; Ragan CI; Ridgill M; Saywell KL; Tricklebank MD J Pharmacol Exp Ther; 1997 Dec; 283(3):1256-63. PubMed ID: 9400001 [TBL] [Abstract][Full Text] [Related]
17. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity. Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184 [TBL] [Abstract][Full Text] [Related]
18. Behavioral characterization of the new potent nonselective dopamine agonist pergolide. Helton DR; Modlin DL; Williams PD Arzneimittelforschung; 1992 Jul; 42(7):885-90. PubMed ID: 1418051 [TBL] [Abstract][Full Text] [Related]
19. [Behavioral pharmacology of mianserin hydrochloride, a new antidepressant (author's transl)]. Kamioka T; Sakai Y Nihon Yakurigaku Zasshi; 1980 Sep; 76(6):533-47. PubMed ID: 7193623 [TBL] [Abstract][Full Text] [Related]
20. [Effects of ritodrine hydrochloride on motor nervous system and central nervous system]. Ikeda S; Tsukamoto T Nihon Yakurigaku Zasshi; 1984 Sep; 84(3):311-26. PubMed ID: 6500405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]